DAY 5 - Wednesday, October 9
Welcome
Ophthalmology Times Europe presents the latest news and views from the final day of the Amsterdam ESCRS Congress. On the last day we have reviewed lectures examining aberrometry, Trypan Blue, PMCD and inflammation. We have also featured a couple more products from the exhibition.
LATEST LECTURES
Aberrometry, Trypan Blue, PMCD and inflammation
The last day of this year's ESCRS certainly packed a punch (of information). We have featured some lectures on a new aberrometer, Trypan Blue dye, a novel treatment for advanced PMCD and a report on the inflammatory response post IOL implantation.
» MORE
PRODUCT NEWS
Microincision IOL
B+L has announced the Euroepan launch of INCISE, a microincision IOL, for microincision cataract surgery (MICS) of less than 2 mm. » MORE
Optional software module
Ziemer has released a new optional module for clear corneal incisions (CCI) and corneal relaxing incisions (CRI). » MORE
Closing remarks
We at OTEurope hope you have enjoyed your stay in Amsterdam during this year's ESCRS and have found our meeting briefs to be useful. We will be continuing to cover the exciting and interesting developments from this year's event in upcoming issues so we invite you to keep reading and please do feel free to comment on what we have covered so far.
SOCIAL NETWORKING
Discuss
Join our LinkedIn group, European Ophthalmology, For the latest discussions, jobs, polls and promotions in the ophthalmic community
Follow
Join our 3000 followers and follow us on Twitter to interact with ophthalmologists and industry leaders. You could even be in with a chance of becoming one of our Follow Friday favourites or Tweet of the Week.
Log on
Log on to the OTEurope website for up-to-date news, product profiles, events, surveys and much more.
Subscribe
Subscribe to our weekly e-newsletter for breaking news and the regular survey question. You can also subscribe to the print version of OTEurope by clicking here.
DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times Group. The sponsor does not endorse and is not responsible for the accuracy of the content or for practices or standards of non-sponsor sources. Some of the products reported in this conference brief may not be FDA approved in the United States.
|
